Corporate Presentation

Market Opportunity: Retail Revenue Potential Sensitivity Based on Current 100,000kg Operational Funded Annual Capacity Increasing to 250,000kg Facility Capacity (Flower) Capacity Utilization Process Throughput (Flower) Flower to active cannabinoid conversion (Note A) Active Cannabinoid Content Active Cannabinoid Content Price per Active Component (Note B) [kg] [%] [kg] [%] [kg] [mg] M 100,000 50% 50,000 10% 5,000 5,000M $0.11 100,000 100% 100,000 10% 10,000 10,000M $0.11 250,000 50% 125,000 10% 12,500 12,500M $0.11 [mg] Revenue at retail per annum [$] B $0.550B $1.0B $1.37B a) Cannabinoid recovery from flower ranges between 10%-20%; Active cannabinoid concentration in crude ranges from 70% -80% b) Source: Based on aggregated pricing data per mg on Harvest Medicine website: https://hmed.ca/pricewatch/ ranging between $0.10 - $0.12 per mg. Potential retail revenue is not reflective of future revenue guidance or management expectations for actual financial results. Pricing reflects retail pricing to end consumer in Canadian market inclusive of excise tax of approximately 10%. MediPharm Labs | 7

View entire presentation